The effectiveness of adalimumab maintenance treatment for Crohn's disease and related prognostic factors: a Japanese single-center study

被引：0
|
作者：
Tanaka, H. [1 ]
Miyakawa, M. [1 ]
Nasuno, M. [1 ]
Motoya, S. [1 ]
Imamura, A. [1 ]
机构：
[1] Sapporo Kosei Gen Hosp, IBD Ctr, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词：
D O I：
10.1016/S1873-9946(14)60444-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P323
引用
收藏
页码：S199 / S200
页数：3
相关论文
共 50 条
  • [21] Short-Term Outcomes of Adalimumab for Japanese Patients with Crohn's Disease and Associated Prognostic Factors
    Miyakawa, Maki
    Tanaka, Hiroki
    Nasuno, Masanao
    Motoya, Satoshi
    INFLAMMATORY BOWEL DISEASES, 2016, 22 : S28 - S28
  • [22] Early Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: A Single-Center Study
    Liu, Esther
    Mandel, Jordan
    Battat, Robert
    Longman, Randy
    Scherl, Ellen
    Lukin, Dana
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S759 - S760
  • [23] Effectiveness of Adalimumab for the Treatment of Extraintestinal Manifestations of Crohn's Disease
    Barreiro, Manuel
    Lorenzo, Aurelio
    Seoane, Montserrat
    Dominguez-Munoz, Enrique
    GASTROENTEROLOGY, 2010, 138 (05) : S692 - S692
  • [24] MORTALITY AND ITS RELATED FACTORS IN PATIENTS WITH IGG4-RELATED DISEASE: A JAPANESE SINGLE-CENTER STUDY
    Mizushima, I.
    Kawahara, H.
    Yoshinobu, T.
    Shin, S.
    Hoshiba, R.
    Nishioka, R.
    Zoshima, T.
    Hara, S.
    Suzuki, Y.
    Ito, K.
    Kawano, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 956 - 957
  • [25] Infliximab for the treatment of Crohn's disease: efficacy and safety in a Chinese single-center retrospective study
    Zhou, Youlian
    He, Hanchang
    Wang, Pu
    Zhang, Ting
    Lin, Minyi
    Wang, Hong
    Nie, Yuqiang
    Chen, Ye
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (11) : 1270 - 1275
  • [26] Cost-effectiveness of adalimumab for the maintenance of remission in patients with Crohn's disease
    Loftus, Edward V., Jr.
    Johnson, Scott J.
    Yu, Andrew P.
    Wu, Eric Q.
    Chao, Jingdong
    Mulani, Parvez M.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (11) : 1302 - 1309
  • [27] PROGNOSTIC FACTORS FOR LONG-TERM ADALIMUMAB TREATMENT IN CROHN'S DISEASE : A MULTICENTER EXPERIENCE
    Pariente, Benjamin
    Duveau, Nicolas
    Perignon, Claire-Anne
    Lepeut, Gabriel
    Lahaye, Anouck
    le Baut, Guillaume
    Rouillon, Clea
    Yzet, Clara
    Loreau, Julien
    Wils, Pauline
    Nachury, Maria
    Fumery, Mathurin
    Viennot, Stephanie
    GASTROENTEROLOGY, 2019, 156 (06) : S879 - S879
  • [28] Ustekinumab for the treatment of refractory pediatric Crohn's disease: a single-center experience
    Cohen, Alexandra
    Ahmed, Najma
    Sant'Anna, Ana
    INTESTINAL RESEARCH, 2021, 19 (02) : 217 - 224
  • [29] A single-center experience with methotrexate in the treatment of Chinese Crohn's disease patients
    Wang, Tian Rong
    Qiao, Yu Qi
    Zou, Duo Wu
    Ran, Zhi Hua
    JOURNAL OF DIGESTIVE DISEASES, 2018, 19 (12) : 753 - 758
  • [30] Comparative efficacy of Infliximab, Adalimumab, and Ustekinumab in patients with biologics naive Crohn's disease:a retrospective observational single-center study
    Sakurai, K.
    Takahashi, S.
    Fujihata, K.
    Watanabe, R.
    Nishimura, Y.
    Yamada, R.
    Sawada, K.
    Sano, I.
    Oda, H.
    Miyagishima, T.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1271 - I1271
12345